241 related articles for article (PubMed ID: 8321198)
1. Control of fibroblast growth factor receptor kinase signal transduction by heterodimerization of combinatorial splice variants.
Shi E; Kan M; Xu J; Wang F; Hou J; McKeehan WL
Mol Cell Biol; 1993 Jul; 13(7):3907-18. PubMed ID: 8321198
[TBL] [Abstract][Full Text] [Related]
2. Heparan sulfate fibroblast growth factor receptor complex: structure-function relationships.
McKeehan WL; Kan M
Mol Reprod Dev; 1994 Sep; 39(1):69-81; discusison 81-2. PubMed ID: 7999363
[TBL] [Abstract][Full Text] [Related]
3. A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-gamma 1.
Mohammadi M; Honegger AM; Rotin D; Fischer R; Bellot F; Li W; Dionne CA; Jaye M; Rubinstein M; Schlessinger J
Mol Cell Biol; 1991 Oct; 11(10):5068-78. PubMed ID: 1656221
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor receptor (FGFR) 3. Alternative splicing in immunoglobulin-like domain III creates a receptor highly specific for acidic FGF/FGF-1.
Chellaiah AT; McEwen DG; Werner S; Xu J; Ornitz DM
J Biol Chem; 1994 Apr; 269(15):11620-7. PubMed ID: 7512569
[TBL] [Abstract][Full Text] [Related]
5. Alternately spliced NH2-terminal immunoglobulin-like Loop I in the ectodomain of the fibroblast growth factor (FGF) receptor 1 lowers affinity for both heparin and FGF-1.
Wang F; Kan M; Yan G; Xu J; McKeehan WL
J Biol Chem; 1995 Apr; 270(17):10231-5. PubMed ID: 7730327
[TBL] [Abstract][Full Text] [Related]
6. A novel type I fibroblast growth factor receptor activates mitogenic signaling in the absence of detectable tyrosine phosphorylation of FRS2.
Lopez ME; Korc M
J Biol Chem; 2000 May; 275(21):15933-9. PubMed ID: 10748122
[TBL] [Abstract][Full Text] [Related]
7. Identification of tyrosines 154 and 307 in the extracellular domain and 653 and 766 in the intracellular domain as phosphorylation sites in the heparin-binding fibroblast growth factor receptor tyrosine kinase (flg).
Hou J; McKeehan K; Kan M; Carr SA; Huddleston MJ; Crabb JW; McKeehan WL
Protein Sci; 1993 Jan; 2(1):86-92. PubMed ID: 8443592
[TBL] [Abstract][Full Text] [Related]
8. Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis without affecting mitogenesis.
Mohammadi M; Dionne CA; Li W; Li N; Spivak T; Honegger AM; Jaye M; Schlessinger J
Nature; 1992 Aug; 358(6388):681-4. PubMed ID: 1379698
[TBL] [Abstract][Full Text] [Related]
9. FRS2 proteins recruit intracellular signaling pathways by binding to diverse targets on fibroblast growth factor and nerve growth factor receptors.
Ong SH; Guy GR; Hadari YR; Laks S; Gotoh N; Schlessinger J; Lax I
Mol Cell Biol; 2000 Feb; 20(3):979-89. PubMed ID: 10629055
[TBL] [Abstract][Full Text] [Related]
10. Expression and immunochemical analysis of rat and human fibroblast growth factor receptor (flg) isoforms.
Xu J; Nakahara M; Crabb JW; Shi E; Matuo Y; Fraser M; Kan M; Hou J; McKeehan WL
J Biol Chem; 1992 Sep; 267(25):17792-803. PubMed ID: 1325449
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor receptor-4 shows novel features in genomic structure, ligand binding and signal transduction.
Vainikka S; Partanen J; Bellosta P; Coulier F; Birnbaum D; Basilico C; Jaye M; Alitalo K
EMBO J; 1992 Dec; 11(12):4273-80. PubMed ID: 1385111
[TBL] [Abstract][Full Text] [Related]
12. Ligand-specific structural domains in the fibroblast growth factor receptor.
Wang F; Kan M; Xu J; Yan G; McKeehan WL
J Biol Chem; 1995 Apr; 270(17):10222-30. PubMed ID: 7730326
[TBL] [Abstract][Full Text] [Related]
13. Common and specific determinants for fibroblast growth factors in the ectodomain of the receptor kinase complex.
Wang F; Lu W; McKeehan K; Mohamedali K; Gabriel JL; Kan M; McKeehan WL
Biochemistry; 1999 Jan; 38(1):160-71. PubMed ID: 9890894
[TBL] [Abstract][Full Text] [Related]
14. Interaction of fibroblast growth factor receptor 3 and the adapter protein SH2-B. A role in STAT5 activation.
Kong M; Wang CS; Donoghue DJ
J Biol Chem; 2002 May; 277(18):15962-70. PubMed ID: 11827956
[TBL] [Abstract][Full Text] [Related]
15. Exon skipping causes alteration of the COOH-terminus and deletion of the phospholipase C gamma 1 interaction site in the FGF receptor 2 kinase in normal prostate epithelial cells.
Yan G; McBride G; McKeehan WL
Biochem Biophys Res Commun; 1993 Jul; 194(1):512-8. PubMed ID: 8333865
[TBL] [Abstract][Full Text] [Related]
16. Basic fibroblast growth factor is a substrate for protein phosphorylation and is phosphorylated by capillary endothelial cells in culture.
Feige JJ; Baird A
Proc Natl Acad Sci U S A; 1989 May; 86(9):3174-8. PubMed ID: 2541433
[TBL] [Abstract][Full Text] [Related]
17. Differential tyrosine phosphorylation of fibroblast growth factor (FGF) receptor-1 and receptor proximal signal transduction in response to FGF-2 and heparin.
Lundin L; Rönnstrand L; Cross M; Hellberg C; Lindahl U; Claesson-Welsh L
Exp Cell Res; 2003 Jul; 287(1):190-8. PubMed ID: 12799194
[TBL] [Abstract][Full Text] [Related]
18. Systematic mapping of potential binding sites for Shc and Grb2 SH2 domains on insulin receptor substrate-1 and the receptors for insulin, epidermal growth factor, platelet-derived growth factor, and fibroblast growth factor.
Ward CW; Gough KH; Rashke M; Wan SS; Tribbick G; Wang J
J Biol Chem; 1996 Mar; 271(10):5603-9. PubMed ID: 8621421
[TBL] [Abstract][Full Text] [Related]
19. Demonstration of functionally different interactions between phospholipase C-gamma and the two types of platelet-derived growth factor receptors.
Eriksson A; Nånberg E; Rönnstrand L; Engström U; Hellman U; Rupp E; Carpenter G; Heldin CH; Claesson-Welsh L
J Biol Chem; 1995 Mar; 270(13):7773-81. PubMed ID: 7535778
[TBL] [Abstract][Full Text] [Related]
20. Binding of the Src SH2 domain to phosphopeptides is determined by residues in both the SH2 domain and the phosphopeptides.
Bibbins KB; Boeuf H; Varmus HE
Mol Cell Biol; 1993 Dec; 13(12):7278-87. PubMed ID: 7504171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
